4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-033620
Chief Executive Officer acquired 1,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOUSE JACQUALYN A Chief Executive Officer | 2019-05-31 | Option exercise | +1,400 | 1,400 | D | ||
| Derivatives | |||||||
| FOUSE JACQUALYN A Chief Executive Officer | 2019-05-31 | Option exercise · Restricted stock units | −1,400 | 0 | D | ||
Loading xslF345X03/doc4.xml…